Savant Capital’s Merck MRK Stock Holding History

Savant Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,886	Closed	-$139K	–	504
2021 Q1	$139K	Buy	+1,886	New	+$139K	0.01%	458

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Savant Capital's MRK Position: Q2 2026 in Review

Savant Capital increased its Merck (MRK) stake by 106% in Q2 2026, buying an estimated $13.3M and bringing the position to 220,270 shares worth $27.5M. The position accounts for 0.08% of the portfolio, ranked #163.

Savant Capital first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Savant Capital held 220,270 shares of Merck worth $27.5M as of Q2 2026.
Savant Capital bought 113,335 Merck shares in Q2 2026, an estimated $13.3M.
Merck made up 0.08% of Savant Capital's portfolio in Q2 2026, its #163 holding.
Savant Capital first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.